Figure 3.
Impact of type I IFN auto-Abs on mortality risk in critically ill COVID-19 patients, analyzed using the Kaplan–Meier method and stratified by age. (A–C) (A) Overall subjects, (B) <60 years old, and (C) ≥60 years old.
Impact of type I IFN auto-Abs on mortality risk in critically ill COVID-19 patients, analyzed using the Kaplan–Meier method and stratified by age. (A–C) (A) Overall subjects, (B) <60 years old, and (C) ≥60 years old.